Skip to main content
Clinical Trials/ACTRN12616001342404
ACTRN12616001342404Recruiting未知

Hole Closure in Vitrectomy with internal limiting membrane repositioning and autologous blood for Macular hole retinal detachment repair in High myopes

Kowloon Central Cluster Grant0 sites30 target enrollmentStarted: September 26, 2016Last updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomised trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • 1. Patients with macular hole retinal detachment (MHRD) with highly myopic eyes (defined as greater than or equal to 6D diopters or axial length greater than or equal to 26.5mm)
  • 2. Age more than 18 years old

Exclusion Criteria

  • 1. History of retinal detachment (RD) or proliferative vitreoretinopathy (PVR)
  • 2. History of intraocular surgery, with the exception of retinal laser photocoagulation or peripheral iridotomy, and cataract surgery
  • 3. Macular hole secondary to other causes
  • 4. Diabetic retinopathy, vitreous haemorrhage, retinal vascular occlusion, uveitis, trauma, optic atrophy, glaucoma, or corneal opacity.
  • 5. Patients who cannot comply with any facedown positioning

Investigators

Sponsor
Kowloon Central Cluster Grant

Similar Trials